Galafold (Migalastat) Approval with UnitedHealthcare in Washington: Answers to the Most Common Questions
Answer Box: Getting Galafold Covered by UnitedHealthcare in Washington
UnitedHealthcare requires prior authorization for Galafold (migalastat) with proof of Fabry disease diagnosis and an amenable GLA variant confirmed by in vitro assay. Initial approval lasts 12 months; reauthorization requires documented positive clinical response. If denied, Washington residents can appeal through